Next |
home / stock / crmd / crmd message board
Subject | By | Source | When |
---|---|---|---|
$CRMD CorMedix Inc. Announces Pricing of $40 Million | TheFinalCD | investorshub | 06/29/2023 3:00:11 AM |
$CRMD Good read | thumper1 | investorshub | 06/28/2023 4:59:11 PM |
The trading last up | DavidW2 | investorshub | 06/26/2023 6:55:31 PM |
Price now | now invest | investorshub | 06/25/2023 3:47:21 PM |
$CRMD MomentumIts gaining last up | Teivel | investorshub | 06/24/2023 2:09:48 PM |
See no one watching.... yet just | now invest | investorshub | 06/20/2023 5:25:51 PM |
news out | Yaafah | investorshub | 06/20/2023 1:53:36 AM |
$CRMD Price trading last up | voisybay123 | investorshub | 06/19/2023 11:02:27 AM |
$CRMD bears and bulls | Lazerking40 | investorshub | 06/19/2023 8:27:59 AM |
$CRMD The now | Yaafah | investorshub | 06/16/2023 4:02:27 PM |
$CRMD Good read | thumper1 | investorshub | 06/14/2023 5:05:39 PM |
$CRMD The now | reslabrat | investorshub | 06/14/2023 3:41:40 AM |
Price gaining | TheFinalCD | investorshub | 06/13/2023 7:31:31 AM |
$CRMD short squeeze | Teivel | investorshub | 06/13/2023 2:50:56 AM |
The trading last trade up | nsomniyak | investorshub | 06/12/2023 4:36:37 AM |
$CRMD got some short data | DavidW2 | investorshub | 06/08/2023 2:55:14 AM |
what do you make of this data? | thumper1 | investorshub | 06/08/2023 1:31:03 AM |
$CRMD Thoughts on where this is headed? | Yaafah | investorshub | 06/07/2023 7:43:36 PM |
$CRMD Price gaining up | Expresso123 | investorshub | 06/05/2023 7:48:28 AM |
best news of the day | Teivel | investorshub | 06/02/2023 11:34:36 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BERKELEY HEIGHTS, N.J., July 03, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has commenced commercialization of DefenCath ® (tauroli...
BERKELEY HEIGHTS, N.J., June 18, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that the U.S. Food and Drug Administration (FDA) has...